CytexOrtho

CytexOrtho is a medical technology company targeting those suffering from osteoarthritis.

This condition may typically be associated with older people. But millions ages eighteen to fifty five suffer from osteoarthritis (OA), too. For these folks, there are no treatment options that will fully restore their mobility, short of undergoing a complete joint replacement.

CytexOrtho offers an alternative option. It’s created a biodegradable implant that restores joint cartilage and bone, instead of replacing it with artificial materials.

This company’s technology is backed by twenty years of research, research that includes five issued patents and seventeen million dollars in grants from the National Institutes of Health (NIH).

CytexOrtho is preparing to submit its product to the FDA through an Investigational Device Exemption. This will allow the device to be used in a clinical study to gather safety/effectiveness data.

Team Background

Bradley Estes - Chief Executive Officer

Franklin Moutos - VP of Technology

Co-Investors